Epic Research

Wednesday, September 17, 2014

Aurobindo Pharma Update by Epic Research

Epic Update Aurobindo PharmaAurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Amoxicillin for Oral Suspension USP 125mg/5mL and 250mg/5mL.

Real Time News & Trading Trends Keep Liking Epic Research Private Limited

FacebookTwitterYouTubePinterestLinkedin - Google+

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

No comments:

Post a Comment